A case of unresectable combined hepatocellular and cholangiocarcinoma treated with atezolizumab plus bevacizumab-Reference-Cited by-同舟云学术

A case of unresectable combined hepatocellular and cholangiocarcinoma treated with atezolizumab plus bevacizumab

Published:2022-07 Issue:7 Volume:10 Page:
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clinical Case Reports

Author:

Saito Naoto¹,Hatanaka Takeshi¹^ORCID,Nakano Sachi¹,Hazama Yoichi¹,Yoshida Sachiko¹,Hachisu Yoko¹,Tanaka Yoshiki¹,Yoshinaga Teruo¹,Kashiwabara Kenji²,Kubo Norio³,Hosouchi Yasuo³,Tojima Hiroki⁴,Kakizaki Satoru⁴⁵^ORCID,Uraoka Toshio⁴

Affiliation:

1. Department of Gastroenterology Gunma Saiseikai Maebashi Hospital Maebashi Japan

2. Department of Pathology Gunma Saiseikai Maebashi Hospital Maebashi Japan

3. Department of Surgery Gunma Saiseikai Maebashi Hospital Maebashi Japan

4. Department of Gastroenterology and Hepatology Gunma University Graduate School of Medicine Maebashi Japan

5. Department of Clinical Research National Hospital Organization Takasaki General Medical Center Takasaki Japan

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.6129

Reference26 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Updates in the diagnosis of combined hepatocellular-cholangiocarcinoma

3. Combined hepatocellular-cholangiocarcinoma: An update

4. Combined hepatocellular-cholangiocarcinoma: a population level analysis of incidence and mortality trends

5. Biphenotypic Primary Liver Carcinomas: Assessing Outcomes of Hepatic Directed Therapy

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The current status and future of targeted-immune combination for hepatocellular carcinoma;Frontiers in Immunology;2024-08-05

2. Combined hepatocellular cholangiocarcinoma: A clinicopathological update;World Journal of Hepatology;2024-05-27

3. Combined hepatocellular-cholangiocarcinoma: from genesis to molecular pathways and therapeutic strategies;Journal of Cancer Research and Clinical Oncology;2024-05-23

4. A Case of Unresectable Combined Hepatocellular-cholangiocarcinoma Treated with Combination Therapy Consisting of Durvalumab Plus Tremelimumab;Internal Medicine;2024

5. Current advances and future directions in combined hepatocellular and cholangiocarcinoma;Gastroenterology Report;2023-12-22